Company Filing History:
Years Active: 2024
Title: Elmar Jaeckel: Innovator in Autoimmune Hepatitis Diagnosis
Introduction
Elmar Jaeckel is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the area of autoimmune hepatitis. His innovative approach has the potential to enhance the accuracy of diagnosing this complex condition.
Latest Patents
Elmar Jaeckel holds a patent for a method and means for diagnosing autoimmune hepatitis using autoantibody markers. This patent outlines a method for determining or diagnosing the presence or absence, or the risk of development, or the therapy control of autoimmune hepatitis in a subject. The method involves analyzing the presence of antibodies against the huntingtin interacting protein 1 related protein (HIP1R) or against immunoreactive peptides derived from it. The presence of these antibodies is indicative of the presence, risk of development, or therapy control of autoimmune hepatitis in the subject. This innovative diagnostic tool may assist in the differential diagnosis of hepatitis diseases.
Career Highlights
Elmar Jaeckel is affiliated with the Medizinische Hochschule Hannover, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on the medical community and patient care.
Collaborations
Elmar collaborates with esteemed colleagues, including Richard Taubert and Niklas Thomas Baerlecken. Their combined expertise contributes to the development of groundbreaking diagnostic methods.
Conclusion
Elmar Jaeckel's contributions to the field of autoimmune hepatitis diagnosis exemplify the importance of innovation in medical research. His patented method represents a significant advancement in the ability to diagnose and manage this challenging condition.